Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
Earnings

WELL Health Reports Record FY2025 Results; Canadian Patient Services Adjusted EBITDA Up 43% with Record Free Cash Flow

By The Northwire Desk — AI Analysis Mar 19, 2026 · 06:30 WELL · 4.21 WELL HEALTH TECHNOLOGIES CORP. J
WELL · Price

Executive Summary

  • WELL Health Technologies reported record FY 2025 revenue of $1.40 billion (+52% YoY) and Adjusted EBITDA of $203.7 million (+336% YoY).
  • The company provided 2026 guidance: revenue $1.55‑$1.65 billion; Adjusted EBITDA $175‑$185 million, with a spin‑out plan for WELLSTAR.
  • Post‑year transactions include an Alberta e‑consult platform acquisition (~$45 m pro‑forma revenue), a $400 m senior secured credit facility expansion, and multiple WELLSTAR medical‑billing asset purchases.

Key Details

  • FY 2025 Financial Highlights
  • Revenue: $1.40 bn (52% increase). Normalized revenue (ex‑CM/CRH): $1.35 bn (+34%).
  • Adjusted EBITDA(1): $203.7 m (336% increase); normalized $148.6 m (+17%).
  • Adjusted EBITDA margin: 14.5% vs. 5.1% in 2024.
  • Operating Free Cash Flow to shareholders (FCFA2S): $58.2 m (+19%).

  • Adjusted Net Income: $126.5 m ($0.50/share).

  • Segment Performance

  • Canadian Patient Services: $444.3 m revenue (+39%); Adjusted EBITDA $58.1 m (+43%).
  • U.S. Patient & Provider Services: $763.5 m revenue (+43%).

  • WELLSTAR SaaS subsidiary: $68.1 m revenue (+59%).

  • Operational Metrics

  • Total patient visits 2025: 6.9 m (↑21%).

  • Clinics in Canada end‑2025: 252.

  • Quarterly & Transaction Highlights (Q4 2025)

  • Nov 3, 2025 – HEALWELL restructuring: acquisition of Polyclinic, 50/50 JV, integration of Bio Pharma Services & Canadian Phase Onward, sale of Mutuo interest to WELLSTAR.
  • Nov 13, 2025 – WELLSTAR’s OceanMD wins provincial e‑referral contract (1.7 m referrals/yr).

  • Dec 8, 2025 – WELLSTAR Series B Preferred Share financing: $62 m total ($59 m to investors, ~$3 m to management) at C$1.50/share.

  • Post‑Year Events

  • Feb 1, 2026 – Acquisition of Alberta e‑consult platform + 8 primary‑care clinics (≈$45 m pro‑forma revenue).
  • Feb 4, 2026 – Senior secured credit facility expanded to $400 m with $100 m uncommitted accordion; maturity extended to Jan 2030.

  • Mar 17, 2026 – WELLSTAR acquires two medical‑billing assets: PatientSERV (Ontario) and Lambert Médico Factures (Québec), extending billing coverage to six provinces.

  • Guidance & Outlook for FY 2026

  • Revenue target: $1.55‑$1.65 bn.
  • Adjusted EBITDA target: $175‑$185 m.
  • Assumes ~$17.6 m deferred Circle Medical revenue recognized in 2026 (≈100% contribution to Adjusted EBITDA).
  • Canada focus: >$800 m revenue and >$100 m Adjusted EBITDA within 18 months (incl. acquisitions).

  • Ongoing sale process for U.S. care‑delivery assets (Wisp, Circle Medical, CRH).

  • Conference Call – March 19, 2026 at 1:00 pm ET; dial‑in 1‑800‑717‑1738 (Toll Free) / 1‑289‑514‑5100 (International); webcast at https://well.company/events.

Notable Quotes

  • Hamed Shahbazi, Chairman & CEO: “2025 was a defining year…we are well positioned to accelerate growth in our highest‑return market while unlocking value from our US portfolio.”
  • Eva Fong, CFO: “Our expanded credit facility and strong cash flow give us the flexibility to continue executing an aggressive Canadian acquisition pipeline.”
Read the original news release →

More from WELL HEALTH TECHNOLOGIES CORP. J

Jun 12, 2026 · 07:02

WELL Health Provides a Corporate Update on Circle Medical

Production / Operations Jun 02, 2026 · 06:31

WELL Health Improves Guidance Based on WELL Canada Achieving $100 Million in Annualized Adjusted EBITDA Run-Rate Ahead of Schedule

M&A / Property May 19, 2026 · 07:01

WELL Health Renews Share Buyback Amidst Strong Earnings Growth and Strategic Spin-Out Plans

Other May 07, 2026 · 16:01

WELL Health Q1 Earnings Beat Revenue Targets But Cash Flow Divergence Raises Liquidity Concerns

Earnings Apr 21, 2026 · 07:01

Margin Expansion Validates Operational Leverage Amidst U.S. Asset Divestiture Uncertainty

Production / Operations Apr 14, 2026 · 07:30

WELL Health Technologies Corp.

Production / Operations